Chronic sinusitis is a condition where inflammation ... When sinusitis does not respond to treatment, your doctor may recommend surgery to remove a polyp or nasal tissue.

GSK (GSK) announced that the China National Medical Products Administration has approved Nucala, a monoclonal antibody that ...

Knowing that you have chronic sinusitis might result in treatments that resolve symptoms, even if you've taken allergy meds ...

Discover why US Vice President-elect JD Vances sinus surgery highlights the importance of addressing chronic sinus issues ...

Patients at highest risk for acute invasive fungal sinusitis are poorly controlled diabetics and those with conditions that predispose to metabolic acidosis such as chronic renal failure or diarrhea.

On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...

London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a ...

Basic research interests of the faculty include dysfunctional sinonasal epithelial ion transport, novel treatment strategies for chronic ... novel surgical methods to improve Cystic Fibrosis-related ...

It is estimated that about 107 million people in China suffer from chronic sinusitis, about 1/3 of ... approved in China as an add-on maintenance treatment for adults and adolescents aged 12 ...